Stockscreener 앱 받기
2.89
4.33%
0.12
시간 외 거래:
2.89
전일 마감가:
$2.77
열려 있는:
$2.815
하루 거래량:
2,759
Relative Volume:
0.42
시가총액:
$4.32M
수익:
$2.54M
순이익/손실:
$-4.13M
주가수익비율:
-1.0509
EPS:
-2.75
순현금흐름:
$-4.11M
1주 성능:
+3.21%
1개월 성능:
+17.24%
6개월 성능:
-23.65%
1년 성능:
-32.32%
1일 변동 폭
$2.78
$2.89
1주일 범위
$2.6612
$2.9218
52주 변동 폭
$2.20
$5.20
Xenetic Biosciences Inc Stock (XBIO) Company Profile
명칭
Xenetic Biosciences Inc
전화
781-778-7720
주소
945 CONCORD ST., FRAMINGHAM, MA
XBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.89 | 4.32M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-01-08 | 개시 | Maxim Group | Buy |
Xenetic Biosciences Inc 주식(XBIO)의 최신 뉴스
Xenetic Biosciences Inc expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Xenetic Biosciences, Inc. Announces Executive Leadership Transition - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Xenetic Biosciences (XBIO) to Release Earnings on Thursday - Defense World
Xenetic Biosciences, Inc. Reports 2018 Year End Results and Provides Corporate Update - ACCESS Newswire
Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results - ACCESS Newswire
Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board - ACCESS Newswire
Xenetic Biosciences, Inc. Receives Approval to Commence Exploratory Study of XCART(TM) - ACCESS Newswire
Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Update - Defense World
Analyzing Ampio Pharmaceuticals (NYSE:AMPE) & Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences (NASDAQ:XBIO) Earns Neutral Rating from HC Wainwright - Defense World
Xenetic Biosciences appoints new accounting firm By Investing.com - Investing.com Canada
Xenetic Biosciences appoints new accounting firm - Investing.com
Wainwright maintains Neutral on Xenetic shares after segment - Investing.com
Wainwright maintains Neutral on Xenetic shares after segment By Investing.com - Investing.com South Africa
Xenetic Biosciences, Inc. Releases Virtual Investor "What This M - GuruFocus
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment - guardonline.com
Xenetic Biosciences Inc (XBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):